The study assessed the safety and effectiveness of a specific prostate surgery (photoselective vaporization) for treating benign prostatic hyperplasia (BPH) in 229 patients over four years.
The patients, mainly around 71 years old, experienced significant improvements in symptoms and urine flow shortly after the surgery, with a noticeable reduction in prostate size and issues like postvoid residual urine.
The results indicated that this surgical method is generally safe, with minimal complications, and maintained positive outcomes for up to two years post-operation.